News

NANJING/SUZHOU, China and COLOGNE, Germany and SINGAPORE, March 7, 2022 /PRNewswire/ — Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platform…

Singleron Completes Series B Financing, Raising Close to $100M Singleron Biotechnologies, an innovative biotech company dedicated to applying groundbreaking single cell multi-omics technologies to clinical…

Learn about the brand-new PythoN® Tissue Dissociation System, perfect for single cell sequencing, Flow cytometry, Cell sorting, CITE-seq. Fast: intelligent workflow within 15 min Low-input:…

Jun 22, 2021 GenomeWeb, one of the most influential online news organizations, reports on Singleron’s work in bringing single cell technologies to clinics in an…

Singleron Biotechnologies, a yound and fast growing company developing high-throughput single-cell multiomics platform products with a focus on clinical applications, recently completed Series A2 financing,…

A milestone study on COVID-19 pathology: This cohort autopsy study, defining COVID-19 systemic pathogenesis, was published in Cell Research on June 16, 2021 (Cell Research…

Camebridge, MS, USA; Beijing &Nanjing, China. March 2021 Singleron Biotechnologies, an innovative single-cell analysis solution provider, recently announced a drug discovery partnership with XtalPi Inc.,…

Nanjing, January 26, 2021. Today Singleron Biotechnologies announced its collaboration with Agilent Technologies Inc. (NYSE: A) to accelerate the development and application of single cell…

Singleron Biotechnologies, a yound and fast growing company, developing high-throughput single-cell multiomics platform products, recently completed Series A1 financing of more than $10M, less than…